Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
OnKure Therapeutics Inc (NASDAQ: OKUR) closed the day trading at $8.61 down -1.37% from the previous closing price of $8.73. In other words, the price has decreased by -$1.37 from its previous closing price. On the day, 0.51 million shares were traded. OKUR stock price reached its highest trading level at $9.4629 during the session, while it also had its lowest trading level at $8.57.
Ratios:
For a better understanding of OKUR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 57.86 and its Current Ratio is at 57.86. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on December 05, 2024, initiated with a Outperform rating and assigned the stock a target price of $33.
On October 10, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $35.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 25 ’24 when Leonard Braden Michael bought 68,746 shares for $1.50 per share. The transaction valued at 102,872 led to the insider holds 3,457,395 shares of the business.
Leonard Braden Michael bought 29,600 shares of OKUR for $41,866 on Sep 24 ’24. The 10% Owner now owns 3,388,649 shares after completing the transaction at $1.41 per share. On Sep 17 ’24, another insider, Leonard Braden Michael, who serves as the 10% Owner of the company, bought 55,300 shares for $1.36 each. As a result, the insider paid 75,108 and bolstered with 3,358,243 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, OKUR now has a Market Capitalization of 114852232 and an Enterprise Value of 243759120.
Stock Price History:
Over the past 52 weeks, OKUR has reached a high of $20.00, while it has fallen to a 52-week low of $8.65. The 50-Day Moving Average of the stock is -45.93%, while the 200-Day Moving Average is calculated to be -46.14%.
Shares Statistics:
Over the past 3-months, OKUR traded about 66.95K shares per day on average, while over the past 10 days, OKUR traded about 114750 shares per day. A total of 3.34M shares are outstanding, with a floating share count of 2.44M. Insiders hold about 27.12% of the company’s shares, while institutions hold 137.13% stake in the company. Shares short for OKUR as of 1732838400 were 1121953 with a Short Ratio of 16.76, compared to 1730332800 on 924624.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 2 analysts currently analyzing and rating the stock of OnKure Therapeutics Inc (OKUR).The consensus estimate for the next quarter is -$1.19, with high estimates of -$1.19 and low estimates of -$1.19.
Analysts are recommending an EPS of between -$1.08 and -$1.08 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$3.1, with 2.0 analysts recommending between -$1.22 and -$4.98.